BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/11/2015 4:38:00 PM | Browse: 1320 | Download: 1939
 |
Received |
|
2014-07-06 14:01 |
|
Peer-Review Started |
|
2014-07-07 12:09 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-08-14 13:43 |
|
Revised |
|
2014-09-21 17:09 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-11-11 10:07 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-11-11 10:23 |
|
Articles in Press |
|
2014-11-11 10:59 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2015-02-03 16:53 |
|
Publish the Manuscript Online |
|
2015-02-11 16:38 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Adalimumab-induced interstitial pneumonia in a patient with Crohn’s disease
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
María José Casanova, María Chaparro, Claudia Valenzuela, Carolina Cisneros and Javier P Gisbert |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| CIBEREHD is founded by Instituto de Salud Carlos III |
|
|
| Corresponding Author |
María José Casanova, MD, PhD, Gastroenterology Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IP), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Canillas, 70 2º-G, CP 28002 Madrid, Spain. mjcasanova.g@gmail.com |
| Key Words |
Adalimumab; Anti-tumor necrosis factor; Crohn’s disease; Interstitial pneumonia |
| Core Tip |
Lung injury secondary to anti-tumor necrosis factor (TNF) drugs could cause severe respiratory symptoms in patients exposed to this therapy, and it should be suspected in patients who: have a temporal association between the onset of respiratory symptoms and the exposure to anti-TNF drugs, show a compatible pattern in the biopsy, and offer negative results for infection. There are a few cases reported of adalimumab-lung toxicity in patients with inflammatory bowel disease. Clinical improvement after biologic therapy discontinuation strongly supports the diagnosis. The mechanism by which anti-TNF drugs induce lung injury remains unclear; therefore, the use of another anti-TNF drug should be discouraged.
|
| Publish Date |
2015-02-11 16:38 |
| Citation |
Casanova MJ, Chaparro M, Valenzuela C, Cisneros C, Gisbert JP. Adalimumab-induced interstitial pneumonia in a patient with Crohn’s disease. World J Gastroenterol 2015; 21(7): 2260-2262 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i7/2260.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i7.2260 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
